Publications by authors named "S Burdach"

Claim this Profile
O
Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.
Peter Ruzanov, Valentina Evdokimova, Manideep C Pachva, Alon Minkovich, Zhenbo Zhang, Stefan Eg Burdach

J Clin Invest· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.
Sebastian J Schober, Melanie Thiede, Hendrik Gassmann, Anna Josefine von Ofen, Pia Knoch, Stefan Burdach

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Raphael Koch, Lianne Haveman, Ruth Ladenstein, Benedicte Brichard, Heribert Jürgens, Stefan Burdach

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
Mansour Poorebrahim, Isaac Quiros-Fernandez, Frederik Marmé, Stefan Eg Burdach, Angel Cid-Arregui

Cancer Lett· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck, Charlotte Middendorf, Julia Lutsch, Stefan E G Burdach

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis